Full Fed. Circ. Urged To Review Inequitable Conduct Ruling
Regeneron Pharmaceuticals Inc. asked the Federal Circuit on Tuesday for a full-court rehearing of its panel decision finding that its patent on a genetically modified mouse is unenforceable in part due...To view the full article, register now.
Already a subscriber? Click here to view full article